Doyle Wealth Management Gsk PLC Transaction History

Doyle Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$40.46 - $43.52 $97,104 - $104,448	-2,400 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$39.4 - $42.7 $94,560 - $102,480	2,400 New	2,400 $96,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $96,347 - $106,639	-2,498 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$37.8 - $42.69 $94,424 - $106,639	2,498 New	2,498 $95,000
Q1 2018 May 11, 2018	SELL	$36.18 - $40.15 $225,075 - $249,773	-6,221 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$35.34 - $41.9 $219,850 - $260,659	6,221	6,221 $221,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Doyle Wealth Management with notifications on news.